Position in VRTX
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$12,748,717
+$1,719,375 QoQ
Shares Held
28,550
+17.4% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BANQUE PICTET & CIE SA holds $180,153,862 across 15 Biotechnology names. VRTX ranks #2 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
2,748,754 | $139,636,703 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
28,550 | $12,748,717 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,893 | $7,643,727 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
61,846 | $3,593,871 | |
| 5 | GPCR |
Structure Therapeutics Inc.
|
49,367 | $2,379,489 | |
| 6 | IMVT |
Immunovant, Inc.
|
88,660 | $2,202,314 | |
| 7 | AVIR |
Atea Pharmaceuticals, Inc.
|
345,077 | $1,856,514 | |
| 8 | BNTX |
BioNTech SE
|
19,677 | $1,748,891 |
All Filings in VRTX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,748,717 | 28,550 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $11,029,342 | 24,328 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $3,469,147 | 8,858 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $7,540,352 | 16,937 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $5,513,857 | 11,373 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $4,849,716 | 12,043 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $5,234,475 | 11,255 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $11,841,742 | 25,264 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $9,296,542 | 22,240 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $9,443,916 | 23,210 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $9,237,365 | 26,564 | Shares | Sole | 2023-11-27 | |
| 2023-06-30 | $9,896,413 | 28,122 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $8,477,588 | 26,907 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $7,008,113 | 24,268 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $13,478,955 | 46,553 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $17,104,089 | 60,698 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $22,337,988 | 85,596 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $20,313,219 | 92,501 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $6,328,697 | 34,890 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,837,273 | 33,910 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $8,740,006 | 40,672 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $9,268,309 | 39,216 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $588,051 | 2,161 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $535,621 | 1,845 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $405,704 | 1,705 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||